SCM
LONA

Silverarc Capital Management’s LeonaBio Inc LONA Stock Holding History

Silverarc Capital Management’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$27M – 73
2022
Q1 		$27M Buy
+1,000
New +$105K 11.16% 1
2021
Q4 		– Sell
-10,639
Closed -$998K – 75
2021
Q3 		$998K Sell
10,639
-1,159
-10% -$118K 0.56% 58
2021
Q2 		$1.21M Buy
+11,798
New +$2.06M 0.54% 65

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BA
Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Silverarc Capital Management's LONA Position: Q2 2022 in Review

Silverarc Capital Management sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 1,000 shares — an estimated $27M sold.

Silverarc Capital Management first reported a position in LONA in Q2 2021 and held it in 3 quarters. The position peaked at $27M in Q1 2022. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

  • Silverarc Capital Management reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
  • Silverarc Capital Management sold 1,000 LeonaBio Inc shares in Q2 2022, an estimated $27M.
  • Silverarc Capital Management first reported a position in LeonaBio Inc in Q2 2021 and held it in 3 quarters.
  • Silverarc Capital Management's LeonaBio Inc position peaked at $27M in Q1 2022.
  • 98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on Silverarc Capital Management's 13F filing for Q2 2022, filed 25 Jul 2022.